Ferriscan R2-MRI Analysis System
Liver Iron Concentration Imaging Companion Diagnostic For Deferasirox. De Novo DEN130012, from Resonance Health Analysis Services Pty, Ltd. (Irvine, CA). Product code PCS, class 2.
As of Nov 19, 2026, DEN130012 is an FDA De Novo held by Resonance Health Analysis Services Pty, Ltd., granted on Jan 23, 2013 after 21 days, with no recalls tied to it in FDA's recall database.
- Review time: 21 days
- Recalls: 0
- Cited as a predicate by: 1 device
The FerriScan R2-MRI Analysis System is intended to measure liver iron concentration to aid in the identification and monitoring of non-transfusion-dependent thalassemia patients receiving therapy with deferasirox. FDA concludes that this device should be classified into Class II.
- Design
- Clinical calibration (105 pts) and validation (233-pt ESCALATOR subgroup) studies vs. liver biopsy AAS reference
- Enrolled
- 233
- Primary endpoint
- Bias and precision of LIC measurement vs. liver biopsy (Bland-Altman limits of agreement and mean percentage difference); primary safety endpoint not stated
- Result
- Validation: bias 1.9%, Bland-Altman 95% limits of agreement 74 and -71%; mean difference not significantly different from zero in either study
- FerriSmart Analysis SystemK182218 · Resonance Health Analysis Services Pty, Ltd. · Nov 30, 2018
- LiverSmartK213776 · Resonance Health Analysis Services Pty, Ltd. · Dec 29, 2021
- Type
- Direct
- Received
- Jan 2, 2013
- Review panel
- Radiology
- Regulation
- 21 CFR 892.1001
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files